| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 2143937 | Lung Cancer | 2007 | 6 Pages | 
Abstract
												Our data suggest that being overweight can influence the development of hepatic dysfunction in Japanese patients receiving cytotoxic chemotherapy for the treatment of NSCLC, although further investigation is required.
											Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Cancer Research
												
											Authors
												Yoshiro Fujiwara, Katsuyuki Kiura, Katsuyuki Hotta, Masahiro Tabata, Nagio Takigawa, Mitsune Tanimoto, 
											